Stereo-seq OMNI for FFPE Solution Launched

---

BGI’s remarkable journey fighting COVID-19, from BGI’s emergency response since the very beginning of the outbreak to BGI’s battle-proven COVID-19 solutions to provide timely detection and intervention support.  

Check in on the latest news at BGI Australia.

• BGI partners with Minderoo to launch Huo-Yan Laboratory Solution to expedite Australia-wide COVID-19 testing.

Keep an eye out here for our promotions and grants. Be notified when applications open. 

Since the completion of Human Genome Project, BGI has evolved into a genomics giant with a global footprint. Its core capabilities cover research, sequencing services, advanced tools for life sciences, and reading, writing, and storage of genetic resources, 

BGI is committed to multi-disciplinary research in life sciences, biotechnology and healthcare applications. Today, BGI actively participates in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a network of collaborators.

Check out our latest range of MGI sequencing platforms and diagnostic devices. 

We provide a wide array of integrated genomic sequencing services and proteomic services across a broad range of applications in basic research, clinical research, genetic testing and screening, drug discovery and development, agriculture and biodiversity preservation and sustainability.

We believe that partnerships are critical to help foster innovation and growth. We partner with diverse players from research and industry organizations who share our vision. We have formed strong alliances within the genomics community and beyond, and continuously seek collaborative opportunities.

We are committed to our customers’ success, and aim for excellence as we work together to find new ways to engage, support customers and identify exciting development opportunities.